Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by GLAXOSMITHKLINE
FDA Drug Application 020236 by GLAXOSMITHKLINE
Application Number
020236
Application Type
New Drug Application
Sponsor Applicant
GLAXOSMITHKLINE
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Priority
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
2/4/1994
N
13176
000
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm108111.htm
11/30/2005
AP
0
7/9/1996
SLR
AP
0
10/15/1996
SCS
AP
0
12/23/1994
SCS
AP
0
3/14/1995
SCS
AP
0
12/23/1994
SLR
AP
0
7/19/1995
SCS
23331
010
http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020236_S010_SERVENT_INHALATION_AEROSOL.pdf
9/16/2009
AP
0
11/13/1995
SCS
AP
0
8/6/1996
SCM
AP
0
11/26/1997
SLR
AP
0
2/5/1998
SE1
AP
0
5/11/1998
SLR
AP
0
12/24/1998
SLR
6431
017
http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020236s017_serevent_toc.cfm
8/7/2003
AP
0
2/25/2000
SLR
AP
0
6/29/2000
SE8
AP
0
6/15/2000
SCS
AP
0
5/17/2001
SLR
AP
0
10/16/2001
SCS
AP
0
8/11/2003
SLR
6492
028
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20236slr028ltr.pdf
8/14/2003
AP
0
8/11/2003
SLR
6494
028
http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20236slr028_serevent_lbl.pdf
8/14/2003
AP
0
8/11/2003
SLR
20399
028
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020236_s028_SEREVENT_INHALATION.pdf
8/1/2008
AP
0
9/28/2004
SLR
10345
030
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21077s022,20236s030,20692s026ltr.pdf
10/4/2004
AP
0
9/28/2004
SLR
10348
030
http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20236s030,20692s026lbl.pdf
10/4/2004
Back to FDA Applications sponsored by GLAXOSMITHKLINE